Illumina | ILMN - Stammkapital

Aktienkurs
127.88
Täglich Wechseln
2.44 1.95%
Monatlich
1.33%
Jährlich
65.33%
Q2 Prognose
131.54




Stammkapital Veränderung Datum
Agilent USD 282.7M 358K 2025-12
Bio Techne USD 155.75M 154.18M 2025-09
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Boston Scientific USD 1.48B 2.66M 2025-12
Bruker USD 151.94M 225K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 199.5M 196.5M 2025-09
Edwards Lifesciences USD 580.7M 0 2025-12
Illumina USD 152.8M 900K 2025-12
Intuitive Surgical USD 355.17M 674K 2026-03
IQVIA Holdings USD 169.6M 700K 2025-12
Laboratory Of America USD 82.2M 700K 2025-12
Mettler Toledo International USD 20.43M 170.6K 2025-12
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quest Diagnostics USD 111M 1000K 2026-03
Quidel USD 67.9M 200K 2025-09
Repligen USD 56.32M 42K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
Standard Biotools USD 386.38M 2.77M 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Waters USD 98.08M 38.55M 2025-12